Tuesday - November 3, 2026
Goodwin Advises Rapport Therapeutics on Pricing of Underwritten Offerings of Common Stock and Pre-Funded Warrants and Convertible Notes and Concurrent Private Placement for an Aggregate of $380 Million
October 28, 2026
BOSTON, Massachusetts, Oct. 28 [Category: BizLaw/Legal] -- Goodwin, a law firm, posted the following news release:

* * *

Goodwin Advises Rapport Therapeutics on Pricing of Underwritten Offerings of Common Stock and Pre-Funded Warrants and Convertible Notes and Concurrent Private Placement for an Aggregate of $380 Million

*

The Life Sciences and Capital Markets teams advised Rapport Therapeutics, Inc. ("Rapport") on the pricing of sepa . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products